Oncology Pharma Stock News

But as oncology pharma has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Genentech is handing over 96 million (82 million) in

+2.48 (+7.95%) data as of jun 18, 2021.

Oncology pharma stock news. Get the latest oncology pharma detailed stock quotes, stock trade data, stock price info, and performance analysis, including oncology otc stock investment advice, charts, stats and more. High volatility in oncology pharma inc. Wall street analysts have given oncology pharma a n/a rating, but there may be better buying opportunities in the stock market.

Get the latest oncology pharma inc (onph) stock news and headlines to help you in your trading and investing decisions. Onph oncology pharma inc (pk) volatile ride for oncology pharma inc. Oncology pharma (onph) nasdaq listed.

Dive deeper with interactive charts and top stories of oncology pharma, inc. Oncology pharma is trading at 28.64 as of the 25th of june 2021. Marketbeat just released five new stock ideas, but.

The stock has traded between $31.08 and $36.96 so far today. View the latest onph stock quote and chart on msn money. Stock price up more than 5.97% on monday:

Find the latest oncology pharma inc (onph) stock quote, history, news and other vital information to help you with your stock trading and investing. The stock's open price was 31.33. Stock price on tuesday which ended trading at $34.57:

Shares of onph rose 15% to $24.79 as of thursday at 9:57am. Rating as of jun 7, 2021. Onph | complete oncology pharma inc.

Data is currently not available. Engages in the development, manufacture and commercialization of therapeutics. Oncology pharma ( onph) stock surged today after biopharmaceutical company announced it had submitted its initial application to the nasdaq to begin the process of moving its stock listing from the pink sheets to the capital markets tier of the nasdaq exchange.

Stock price on thursday moving between $30.56 and $35.00 the oncology pharma inc. Company profile page for oncology pharma inc including stock price, company news, press releases, executives, board members, and contact information Its portfolio include nanosmart pharmaceuticals, and tulynode.

The company was founded by marcel van heesewijk on march 26, 1993 and is headquartered in san francisco, ca. And has now fallen 4 days in a row.during the day the stock fluctuated 14.53% from a day low at $30.56 to a day high of $35.00.the price has fallen in 5 of the last 10 days, but is still up by 8.07% over the past 2 weeks. Volume fell on the last day along with the stock, which.

Stock analysis for oncology pharma inc (onph:otc us) including stock price, stock chart, company news, key statistics, fundamentals and company profile. High volatility in oncology pharma inc. Quote stock analysis news price vs fair.

Stock price on wednesday which ended trading at $33.66:

Hr har de mjlighet direkt